000			02110 a2200589 4500
005			20250516043949.0
264		0	_c20111123
008			201111s 0 0 eng d
022			_a1945-7197
024	7		_a10.1210/jc.2010-2771 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrassard, Maryse
245	0	0	_aEndocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer. _h[electronic resource]
260			_bThe Journal of clinical endocrinology and metabolism _cSep 2011
300			_a2741-9 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma, Follicular _xblood
650	0	4	_aAdenocarcinoma, Papillary _xblood
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBlood Glucose
650	0	4	_aCalcium _xblood
650	0	4	_aCross-Over Studies
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aParathyroid Hormone _xblood
650	0	4	_aPiperidines _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins c-ret _xantagonists & inhibitors
650	0	4	_aQuinazolines _xtherapeutic use
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors
650	0	4	_aTestosterone _xblood
650	0	4	_aThyroid Neoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
650	0	4	_aVitamin D _xblood
700	1		_aNeraud, Barbara
700	1		_aTrabado, Séverine
700	1		_aSalenave, Sylvie
700	1		_aBrailly-Tabard, Sylvie
700	1		_aBorget, Isabelle
700	1		_aBaudin, Eric
700	1		_aLeboulleux, Sophie
700	1		_aChanson, Philippe
700	1		_aSchlumberger, Martin
700	1		_aYoung, Jacques
773	0		_tThe Journal of clinical endocrinology and metabolism _gvol. 96 _gno. 9 _gp. 2741-9
856	4	0	_uhttps://doi.org/10.1210/jc.2010-2771 _zAvailable from publisher's website
999			_c20968639 _d20968639